Receive our newsletter – data, insights and analysis delivered to you
  1. News
April 1, 2021updated 16 Apr 2021 3:11pm

Komodo and Janssen sign agreement to accelerate clinical development

Komodo Health and Janssen Research & Development have signed an agreement to use real-world data and artificial intelligence (AI) software for accelerating clinical development.

Komodo Health and Janssen Research & Development have signed an agreement to use real-world data and artificial intelligence (AI) software for accelerating clinical development.

As part of the collaboration, feasibility, site selection, and patient recruitment will be optimised for clinical trials.

This is expected to drive higher throughput for trials and fast track life-saving therapies to patients.

Komodo Health chief medical officer Aswin Chandrakantan said: “The next generation of clinical trials requires deep and timely insight into the patient journey.

“Whether targeting a large volume of diverse patients for a prevalent chronic condition or exploring breakthroughs for complex rare diseases, it’s crucial to understand where patients are progressing through the care system in order to improve efficiency in clinical trials.”

At present, the partnership focuses on software solutions that offer real-time visibility into patient volumes.

Content from our partners
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success
Patient-centric pharma logistics: How CRYOPDP delivers hope worldwide
Why Asia-Pacific is the next frontier for decentralized clinical trials

This improves the ability to identify trial sites, increase target recruitment. Furthermore, patient cohorts could be understood prior to launch, and reach diverse patient populations.

The collaboration will cover therapeutic areas ranging from common chronic illnesses to ultra-rare diseases and its areas include infectious diseases, oncology, vaccines, immunology, cardiovascular, and metabolic disease.

The Komodo Health solutions are built on its Healthcare Map of 325 million US de-identified patient journeys.

Solutions that are being deployed include ‘Prism’ to support patient cohort analytics, ‘Sentinel’ for data integration, analytics, and site selection, and ‘Pulse’ for real-time alerts on encounters between providers and potential screening eligible patients.

Komodo Health applies AI and other advanced data science techniques to its Healthcare Map.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU